$62.57
0.180.29%
At Close: -
15 minutes delayed
Comments
Loading...
Novonesis
NVZMYOTCPK
Novonesis (OTC:NVZMY) Stock, Earnings Estimates, EPS, And Revenue
Novonesis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 1
EPS
$0.360
Quarterly Revenue
$664.2M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$17.9B
Analyze the earnings history of Novonesis using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVZMY | Novozymes | $0.49 | — | — | — | $650.51M | — | — | — | 10/24/2024 | Get Alert |
| NVZMY | Novozymes | $0.32 | — | — | — | $616.52M | — | — | — | 08/07/2024 | Get Alert |
| NVZMY | Novozymes | $0.41 | — | — | — | $666.31M | — | — | — | 08/06/2024 | Get Alert |
| NVZMY | Novozymes | $0.43 | $0.44 | $0.36 | -18.18% | $606.10M | $674.70M | $664.23M | -1.55% | 02/01/2024 | Get Alert |
| NVZMY | Novozymes | $0.56 | $0.42 | $0.49 | 16.67% | $591.68M | $634.28M | $650.51M | 2.56% | 10/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.42 | $0.42 | $0.32 | -23.81% | $614.04M | $632.02M | $616.52M | -2.45% | 08/09/2023 | Get Alert |
| NVZMY | Novozymes | $0.45 | $0.44 | $0.41 | -6.82% | $659.40M | $662.60M | $666.31M | 0.56% | 04/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.34 | $0.41 | $0.43 | 4.88% | $589.85M | $671.94M | $606.10M | -9.80% | 01/26/2023 | Get Alert |
| NVZMY | Novozymes | $0.48 | $0.62 | $0.56 | -9.68% | $596.04M | $622.40M | $591.68M | -4.93% | 11/03/2022 | Get Alert |
| NVZMY | Novozymes | $0.46 | — | $0.42 | — | $579.96M | — | $614.04M | — | 08/11/2022 | Get Alert |
| NVZMY | Novozymes | $0.51 | — | $0.45 | — | $611.99M | — | $659.40M | — | 04/27/2022 | Get Alert |
| NVZMY | Novozymes | $0.37 | $0.36 | $0.34 | -5.56% | $551.36M | $576.38M | $589.85M | 2.34% | 02/01/2022 | Get Alert |
| NVZMY | Novozymes | $0.40 | $0.40 | $0.48 | 20.00% | $538.67M | $582.09M | $596.04M | 2.40% | 10/27/2021 | Get Alert |
| NVZMY | Novozymes | $0.34 | — | $0.46 | — | $494.68M | — | $579.96M | — | 08/12/2021 | Get Alert |
| NVZMY | Novozymes | $0.42 | — | $0.51 | — | $558.41M | — | $611.99M | — | 04/27/2021 | Get Alert |
| NVZMY | Novozymes | $0.49 | — | $0.37 | — | $559.65M | — | $551.36M | — | 02/02/2021 | Get Alert |
| NVZMY | Novozymes | $0.33 | $0.63 | $0.40 | -36.51% | $555.60M | $289.03M | $538.67M | 86.37% | 10/21/2020 | Get Alert |
| NVZMY | Novozymes | $0.47 | — | $0.34 | — | $519.33M | — | $494.68M | — | 08/12/2020 | Get Alert |
| NVZMY | Novozymes | $0.37 | — | $0.42 | — | $529.83M | — | $558.41M | — | 04/29/2020 | Get Alert |
| NVZMY | Novozymes | $0.44 | — | $0.49 | — | $567.89M | — | $559.65M | — | 01/23/2020 | Get Alert |
| NVZMY | Novozymes | $0.41 | — | $0.33 | — | $548.70M | — | $555.60M | — | 10/23/2019 | Get Alert |
| NVZMY | Novozymes | $0.42 | — | $0.47 | — | $559.68M | — | $519.33M | — | 08/08/2019 | Get Alert |
Novonesis (NVZMY) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-01 | $0.36 | $0.44 | -18.2 % |
| Sep 2023 | 2023-10-26 | $0.49 | $0.42 | 16.7 % |
| Jun 2023 | 2023-08-09 | $0.32 | $0.42 | -23.8 % |
| Mar 2023 | 2023-04-26 | $0.41 | $0.44 | -6.82 % |
Novonesis (NVZMY) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2023 | 2024-02-01 | $664.23M | $674.70M | -1.55 % |
| Sep 2023 | 2023-10-26 | $650.51M | $634.28M | 2.56 % |
| Jun 2023 | 2023-08-09 | $616.52M | $632.02M | -2.45 % |
| Mar 2023 | 2023-04-26 | $666.31M | $662.60M | 0.56 % |
FAQ
When is Novonesis (OTCPK:NVZMY) reporting earnings?
Novonesis (NVZMY) is scheduled to report earnings on October 24, 2024. The last reported earnings were for reported on February 1, 2024 for Q4.
What were the latest earnings per share (EPS) for Novonesis (OTCPK:NVZMY)?
The Actual EPS was $0.36, which missed the estimate of $0.44.
What were Novonesis’s (OTCPK:NVZMY) revenues?
The Actual Revenue was $664.2M, which missed the estimate of $674.7M.
Browse earnings estimates, EPS, and revenue on all stocks.